Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a neurodevelopmental disorder featuring chronic, complex neuropsychiatric features. The etiology and pathogenesis of schizophrenia are not fully understood. Oxidative-antioxidant imbalance is a potential determinant of schizophrenia. Oxidative, nitrosative, or sulfuric damage to enzymes of glycolysis and tricarboxylic acid cycle, as well as calcium transport and ATP biosynthesis might cause impaired bioenergetics function in the brain. This could explain the initial symptoms, such as the first psychotic episode and mild cognitive impairment. Another concept of the etiopathogenesis of schizophrenia is associated with impaired glucose metabolism and insulin resistance with the activation of the mTOR mitochondrial pathway, which may contribute to impaired neuronal development. Consequently, cognitive processes requiring ATP are compromised and dysfunctions in synaptic transmission lead to neuronal death, preceding changes in key brain areas. This review summarizes the role and mutual interactions of oxidative damage and impaired glucose metabolism as key factors affecting metabolic complications in schizophrenia. These observations may be a premise for novel potential therapeutic targets that will delay not only the onset of first symptoms but also the progression of schizophrenia and its complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kohen, R., & Nyska, A. (2002) · Toxicologic Pathology · doi:10.1080/01926230290166724 · Cited by 2,178
MTOR: a pharmacologic target for autophagy regulation
Kim, Y. C., & Guan, K.-L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73939 · Cited by 2,126
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 5×
“Under the influence of further oxidation, methionine sulfoxide can be converted to methionine sulfone [157].”
BackgroundResultInfluentialAlzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Reactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091
Vita, A., De Peri, L., Deste, G., & Sacchetti, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.116 · Cited by 453 · cited 4×
“They also have the ability to cross cell membranes into the extracellular space [2] and to mediate cell signaling [1].”
BackgroundInfluentialCorrell, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1314 · Cited by 384
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-019-0090-z · Cited by 359
How does brain insulin resistance develop in Alzheimer's disease?
De Felice, F. G., Lourenco, M. V., & Ferreira, S. T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.004 · Cited by 337
Autophagy-monitoring and autophagy-deficient mice
Kuma, A., Komatsu, M., & Mizushima, N. (2017) · Autophagy · doi:10.1080/15548627.2017.1343770 · Cited by 336 · cited 1×
“Studies on autophagy-related gene mutations (ATG) in animals are largely associated with inability to survive [64].”
BackgroundAntioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Yao, J. K., & Keshavan, M. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3603 · Cited by 285 · cited 1×
“concentration in schizophrenic patients is higher in both the brain and the periphery [171,172].”
BackgroundClinical Practice Guidelines for the management of Depression
Grover, S., Gautam, S., Jain, A., Gautam, M., & Vahia, V. (2017) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.196973 · Cited by 269
Accelerated Gray and White Matter Deterioration With Age in Schizophrenia
Cropley, V. L., Klauser, P., Lenroot, R. K., Bruggemann, J., Sundram, S., Bousman, C., Pereira, A., Di Biase, M. A., Weickert, T. W., Weickert, C. S., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050610 · Cited by 217 · cited 2×
“Interestingly, in the period of rapid neuronal growth in fetal life and late childhood, intracellular hypoglycemia causes the transition of symptoms into chronic deficits, which are manifested by a lack of motivation and a desire to learn, as well as withdrawal of social functions or weakening of interpersonal communi…”
BackgroundOliver, D., Davies, C., Crossland, G., Lim, S., Gifford, G., McGuire, P., & Fusar-Poli, P. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx166 · Cited by 126 · cited 1×
“Depending on the time of diagnosis, early introduction of appropriate pharmacotherapy or psychotherapy of patients and their families guarantees complete recovery after the onset of the first psychotic episode, while its lack becomes the cause of FEP progression into a chronic and full-blown schizophrenia [32] with a…”
BackgroundQuantification of oxidized RNAs in Alzheimer's disease
Shan, X., & Lin, C.-L. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.022 · Cited by 125 · cited 1×
“In turn, RNA oxidative damage can impair protein translation, which leads to reduced expression of proteins and loss of their physiological functions (Table 2) [157,223,224].”
BackgroundRheb and Rags come together at the lysosome to activate mTORC1
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130037 · Cited by 96
Johnson, A. W., Jaaro-Peled, H., Shahani, N., Sedlak, T. W., Zoubovsky, S., Burruss, D., Emiliani, F., Sawa, A., & Gallagher, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307925110 · Cited by 96
Clinical Practice Guidelines for Management of Schizophrenia
Avasthi, A., Grover, S., Chakrabarti, S., & Kulhara, P. (2017) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.196972 · Cited by 75
Glycation affects fibril formation of Aβ peptides
Emendato, A., Milordini, G., Zacco, E., Sicorello, A., Dal Piaz, F., Guerrini, R., Thorogate, R., Picone, D., & Pastore, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002275 · Cited by 65 · cited 1×
“It can slow down the transformation of proteins, which occurs through conversion into the structure of β-harmonica and fibrils, keeping them longer in toxic oligomeric forms [124].”
BackgroundMueser, K. T., DeTore, N. R., Kredlow, M. A., Bourgeois, M. L., Penn, D. L., & Hintz, K. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13102 · Cited by 54
Mayo, D., Bolden, K. A., Simon, T. J., & Niendam, T. A. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.011 · Cited by 32 · cited 3×
“The basic biochemical reactions involving nitric oxide are: S-nitrosylation of thiols, and nitrosylation of transition metal ions [12,79,80].”
BackgroundSinan, K. I., Chiavaroli, A., Orlando, G., Bene, K., Zengin, G., Cziáky, Z., Jekő, J., Fawzi Mahomoodally, M., Picot-Allain, M. C. N., Menghini, L., et al. (2020) · Antioxidants · doi:10.3390/antiox9020163 · Cited by 25
Cited by
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00336-2 · Cited by 79
Mueser, K. T., DeTore, N. R., Kredlow, M. A., Bourgeois, M. L., Penn, D. L., & Hintz, K. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13102 · Cited by 54
Dawidowski, B., Grelecki, G., Biłgorajski, A., Podwalski, P., Misiak, B., & Samochowiec, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010232 · Cited by 22
Metadata
- Authors
- Bryll, A., Skrzypek, J., Krzyściak, W., Szelągowska, M., Śmierciak, N., Kozicz, T., & Popiela, T.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-02
- Volume
- 10
- Issue
- 3
- Pages
- 384
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W3009462395
- Cited by
- 73
- References
- 24
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.